Cargando…

RAAS INHIBITORS ARE CARDIOPROTECTIVE IN PATIENTS WITH COVID-19

Detalles Bibliográficos
Autores principales:	Holmes, Adam R., Nelson, Jacob, Hirschl, Jacob, Perkins, Sidney J., Chopra, Zoey, Fung, Christopher, Medlin, Richard P., Korley, Frederick K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2021
Materias:	Spotlight on Special Topics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091238/ http://dx.doi.org/10.1016/S0735-1097(21)04428-4

Ejemplares similares

Inflammatory Markers Are Not Useful for Identifying Patients With SARS-CoV-2 Infection
por: Korley, Frederick K., et al.
Publicado: (2020)

NO EXCESS MORTALITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR OR ARB USE IN HOSPITALIZED PATIENTS WITH COVID-19
por: Annie, Frank H., et al.
Publicado: (2021)

BIOMARKERS OF INFLAMMATION AND OUTCOMES OF PATIENTS HOSPITALIZED FOR COVID-19: THE INTERNATIONAL STUDY OF INFLAMMATION IN COVID-19
por: Meloche, Chelsea, et al.
Publicado: (2021)

296 A Bayesian Approach to Predicting Outcomes During the Initial COVID-19 Outbreak
por: Nelson, J., et al.
Publicado: (2021)

COMPARISON OF PROGNOSTIC SIGNIFICANCE OF TROPONIN I ELEVATION TO OTHER BIOMARKERS IN PATIENTS HOSPITALIZED WITH COVID 19 INFECTION
por: Jayanna, Manju Bengaluru, et al.
Publicado: (2021)

META-ANALYSIS OF SAFETY AND EFFICACY OF RENIN ANGIOTENSIN ALDOSTERONE SYSTEM INHIBITORS IN COVID-19 POPULATION
por: Sattar, Yasar, et al.
Publicado: (2021)

TIME SINCE LAST CHEMOTHERAPY AND COVID-19 OUTCOMES IN CARDIO-ONCOLOGY INPATIENTS
por: Visaria, Aayush, et al.
Publicado: (2022)

HEMATOLOGICAL ABNORMALITIES IN CARDIOVASCULAR AND CARDIO-ONCOLOGY PATIENTS ARE ASSOCIATED WITH WORSE COVID-19 OUTCOMES
por: Visaria, Aayush, et al.
Publicado: (2022)

41 Clinical Outcomes among COVID-19 Patients Taking Non-Steroidal Anti-Inflammatory Drugs
por: Perkins, S.J., et al.
Publicado: (2020)

ASSOCIATION BETWEEN IN-HOSPITAL MORTALITY AND ACE/ARB INHIBITOR USAGE
por: Ruge, Max, et al.
Publicado: (2022)

63 Incidence and Determinants of COVID-19 Emergency Department Revisits
por: Chopra, Z., et al.
Publicado: (2020)

IMPACT OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS ON MORTALITY DURING THE COVID PANDEMIC AMONG DIABETIC PATIENTS WITH STEMI UNDERGOING MECHANICAL REPERFUSION: INSIGHT FROM AN INTERNATIONAL STEMI REGISTRY
por: De Luca, Giuseppe, et al.
Publicado: (2022)

OUTPATIENT CARDIOVASCULAR ASSESSMENT AND IMAGING FOLLOWING THE DIAGNOSIS OF COVID-19 IN US NAVAL ACADEMY CADETS
por: Klusewitz, Seth, et al.
Publicado: (2021)

ANALYSIS OF PUBLIC ACCESS DEFIBRILLATOR USE PRE- AND DURING THE COVID-19 PANDEMIC
por: Torney, Hannah, et al.
Publicado: (2021)

CARDIAC ABNORMALITIES IN COVID-19 AND RELATIONSHIP TO OUTCOME
por: Krishna, Hema, et al.
Publicado: (2021)

EFFECT OF STATIN IN HOSPITALIZED PATIENTS WITH COVID 19
por: Bonilla, Hilda Mariana Gonzalez, et al.
Publicado: (2021)

RISK FACTORS ASSOCIATED WITH ICU ADMISSION AND DEATH AMONG COVID-19 PATIENTS IN A LARGE ACADEMIC HEALTHCARE NETWORK
por: Meena, Richard, et al.
Publicado: (2021)

LONG TERM CMR CHARACTERIZATION OF ATHLETES RECOVERING FROM COVID-19 INFECTION AND RETURN TO PLAY
por: Wroblewski, Jennifer, et al.
Publicado: (2022)

OBESITY, INFLAMMATION, AND OUTCOMES IN COVID-19
por: Padalia, Kishan, et al.
Publicado: (2021)

CORONARY ARTERY CALCIFICATION HERALDS ADVERSE CLINICAL OUTCOMES IN PATIENTS HOSPITALIZED FOR COVID-19
por: Shabbir, Muhammad Asim, et al.
Publicado: (2021)

CARDIOVASCULAR DISEASE AND OUTCOMES IN CRITICALLY ILL PATIENTS WITH COVID-19: A STOP-COVID ANCILLARY
por: Meloche, Chelsea, et al.
Publicado: (2021)

VASCULAR ENDOTHELIAL GROWTH FACTOR IS ASSOCIATED WITH SEVERE COVID-19 DISEASE
por: Solorzano, Juan, et al.
Publicado: (2022)

INITIAL SINGLE CENTER ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION EXPERIENCE IN NEW YORK BEFORE AND DURING THE COVID-19 PANDEMIC
por: Medranda, Giorgio, et al.
Publicado: (2021)

INFLAMMATION AND VASCULAR REMODELING IN COVID-19 HEARTS
por: Werlein, Christopher, et al.
Publicado: (2022)

STATIN USE MAY BE ASSOCIATED WITH DECREASED SEVERITY OF COVID-19
por: Shadid, Husam, et al.
Publicado: (2021)

THE CARDIONERDS CASE REPORT SERIES: CONNECTING THE CARDIOLOGY COMMUNITY DURING THE COVID-19 PANDEMIC
por: Desai, Karan, et al.
Publicado: (2021)

RETURN TO PLAY EVALUATION POST COVID - LONGITUDINAL EXPERIENCE IN CARDIAC RISK ASSESSMENT AT A DIVISION I ATHLETIC PROGRAM
por: Sivalokanathan, Sanjay, et al.
Publicado: (2023)

CARDIOVASCULAR COMORBIDITIES PREDISPOSE TO CARDIOVASCULAR COMPLICATIONS IN HOSPITALIZED PATIENTS WITH COVID-19 INFECTION
por: Razipour, Shadi, et al.
Publicado: (2022)

COVID-19 ASSOCIATED DECREMENTS IN LEFT VENTRICULAR FUNCTION PREDICT MORTALITY
por: Nambiar, Lakshmi, et al.
Publicado: (2021)

CARDIOMYOPATHIC GENE MUTATIONS ALTER ACE2 EXPRESSION AND INFECTIVITY OF SARS-COV-2 IN HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES
por: Kontorovich, Amy, et al.
Publicado: (2021)

ECHOCARDIOGRAPHIC ABNORMALITIES ARE COMMON AMONG PATIENTS WITH COVID-19 INFECTION AND INDEPENDENTLY CONFER INCREASED RISK OF IN-HOSPITAL MORTALITY
por: Homan, Edwin A., et al.
Publicado: (2021)

FULLY AUTOMATED ANALYSIS OF CARDIAC POINT OF CARE ULTRASOUND: FEASIBILITY AND CLINICAL RELEVANCE IN COVID-19 PATIENTS.
por: Hawkes, Will, et al.
Publicado: (2022)

COVID-19 COMPLICATED BY RESPIRATORY FAILURE INCREASES INPATIENT STEMI MORTALITY: MACHINE LEARNING-AUGMENTED MODIFIED PROPENSITY SCORE ADJUSTED LONGITUDINAL COHORT STUDY
por: Ynalvez, Leslie Ammabel, et al.
Publicado: (2023)

THE IMPACT OF TELEHEALTH ON OUTCOMES IN CARDIOVASCULAR PATIENTS
por: Cioci, Anthony, et al.
Publicado: (2022)

CARDIAC SEQUELAE OF LONG-COVID
por: Howick, James, et al.
Publicado: (2023)

CORONARY MICROVASCULAR HEALTH IN PATIENTS WITH PRIOR COVID-19 INFECTION: IMPLICATIONS FOR LONG-COVID SYNDROME
por: Ahmed, Ahmed Ibrahim, et al.
Publicado: (2022)

WHO IS AT RISK FOR CARDIOMYOPATHY IN COVID 19
por: Daftari, Diana, et al.
Publicado: (2021)

BRADYARRHYTHMIAS AND MORTALITY IN COVID-19 PATIENTS
por: Hoang, Lawrence, et al.
Publicado: (2021)

THE EFFECT OF COVID-19 ON CARDIOVASCULAR PRODUCERS
por: Annie, Frank H., et al.
Publicado: (2021)

CATHETER-DIRECTED THROMBOLYSIS IN COVID-19
por: Ammar, Ali, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n6netp407om1iesacmnd8i0246